Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trialsMichał Marczyk, Lajos Pusztai, Y.-Y. Chen et al.|Annals of Oncology|2022Cited by 22
Intratumor heterogeneity of the estrogen receptor and the long-term risk of fatal Breast cancerC.C. Benz, B. Nordenskjöld, B. Datnow et al.|UNC Libraries|2021Cited by 1